Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

COVID-19 (Coronavirus Disease) is caused by the novel coronavirus SARS-CoV-2, which is a RNA virus. Few of the common symptoms of COVID-19 include fever, dry cough, fatigue, and body ache. COVID-19 disease can be transmitted from one person to another by the inhalation of infectious droplets. People with conditions such as hypertension, cancer, diabetes, old age, and others are at higher risk of getting severe COVID-19 infection. Thus, it is essential to develop efficient nasal swab tests for diagnosis of COVID-19. Rapid research is being carried out to make low cost and accurate nasal swab COVID-19 tests, which is expected to create growth opportunities for this market. Nasal swab tests involve the collection of secretions from the inner surface of nostril. These samples are employed by diagnostic systems such as molecular diagnostic, biosensors, immunoassays, and others. COVID-19 nasal swab tests are widely used by hospitals, clinics, laboratories, diagnostic centers and others.

Global COVID-19 Nasal Swab Test Market - Impact of the Coronavirus (COVID-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020.

According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 186,240,393 cases and 4,027,861 deaths due to coronavirus disease (COVID-19) were reported till July 11, 2021, across the globe.

Impact of COVID-19 on Demand and Supply of COVID-19 Nasal Swab Test

The COVID-19 pandemic and lockdown in various countries across the globe have negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has impacted the entire supply chain of the biotechnology industry mainly due to strict lockdown in several regions. However, the demand for COVID-19 nasal swab test is increasing in this COVID-19 pandemic due to the growing need of diagnostics for the proper detection of COVID-19 infection and to stop its spread.

For instance, in May 2020, Aga Khan University’s Innovation Lab, Pakistan, developed an indigenous, low-cost, 3-D printed prototype of nasal swab for the detection of SARS-CoV-2. This new development would aid the country in meeting the growing demand for innovative diagnostics for COVID-19 amidst surge in coronavirus cases. In November 2020, the clinical trials for this 3-D printed nasal swab were completed, and had shown positive results for the safety and efficacy of these 3 D printed nasal swabs.

Moreover, in September 2020, the University of Melbourne, Australia, and 3D MEDiTech, an Australian medical devices company, accelerated the production of the first indigenous 3-D printed nasal swab for diagnosis of COVID-19. According to clinical trial data published by the Medical Journal of Australia in May 2020, these newly developed 3D printed nasal swabs were found to be at par with commercial nasal swabs. 3D printed nasal swabs would aid in providing a cost effective solution amidst shortage of nasal swabs due to rapid increase in laboratory testing for COVID-19.

Thus, impact of the coronavirus (COVID-19) pandemic is expected to drive the growth of the global COVID-19 nasal swab test market during the forecast period, owing to rising number of COVID-19 cases and rapid research in development of diagnostics for COVID-19 during the pandemic.

The global COVID-19 nasal swab test market is estimated to be valued at US$ 111.3 Mn in 2021, and is expected to exhibit a CAGR of 2.6% over the forecast period (2021-2028).

request-sample

COVID-19 Nasal Swab Test Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 111.3 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2020 to 2027 CAGR: 2.6% 2028 Value Projection: US$ 133.2 Million
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Foam Tipped Swabs, Non-Woven, Others
  • By Diagnostics Type: Molecular Diagnostics, CRISPR & Biosensors, Others
  • By Mode: Point-of-Care, Non Point-of-Care
  • By End User: Hospital & Clinic, Laboratories & Diagnostics Centers, Others 
Companies covered:

Abbott Laboratories, Roche Holding AG, Becton Dickinson & Company, 3M Corporation, BioMerieux SA, Lucira Health, Mesa Biotech, Inc.,Siemens Healthineers AG, QIAGEN N.V., Cepheid, LumiraDx Ltd., Fluidigm Corporation, Quidel Corporation, GenMark Diagnostics, Inc., Sherlock Biosciences, PrivaPath Diagnostics Limited, and OraSure Technologies, Inc.

Growth Drivers:
  • Rising burden of COVID-19 infection
  • Increasing product launches and approvals
Restraints & Challenges:
  • Increasing Product Recalls

Figure 1: Global COVID-19 Nasal Swab Test Market Share (%) Analysis, By Diagnostics Type, 2021

COVID-19 Nasal Swab Test  | Coherent Market Insights

The increasing number of novel coronavirus cases is the major factor that is expected to drive the market growth over the forecast period.

The rising number of novel coronavirus cases is expected to drive growth of COVID-19 nasal swab test market over the forecast period. According to an article published by Healthline Media, an American medical information provider, on June 28, 2021, more than 70,000 new COVID-19 cases are added every week in U.S.

Moreover, increasing number of research and development activities for improving the effectiveness of COVID-19 nasal swab test is expected to aid in the growth of the market over the forecast period. For instance, according to an article published by the National Institutes of Health (NIH), U.S. in July 2020, Helix OpCo, LLC, a California based population genomic company, developed standardized nasal swab kits in bulk for the collection of nasal secretion samples to detect SARS-CoV-2. This will allow processing of thousands of nasal swab samples at once and provide results within 24-48 hours. These COVID-19 nasal swab kits would be shipped to public health departments, employers, healthcare systems, and others.

Rising government funding may support research and development activities, which in turn may support the research and development of new COVID-19 nasal swab tests, which is expected to drive the growth of the global COVID-19 nasal swab tests market over the forecast period. For instance, according to an article published by the National Institutes of Health (NIH), U.S. in July 2020, NIH plans to invest around US$ 248.7 million for making innovative diagnostics solutions for COVID-19.

Global COVID-19 Nasal Swab Test Market – Restraints

However, growth of the COVID-19 nasal swab test market may be hampered, owing to the increasing product recalls. For instance, in May 2020, rapid COVID-19 diagnostic kits manufactured by Spartan Bioscience, Inc., a Canadian biotechnology company, were recalled by Health Canada (department of Government of Canada) due to efficacy concerns of nasal/nasopharyngeal swabs. Thus, Health Canada directed the use of this diagnostic kit for research purposes only while its regulatory approval has been put on hold.

Global COVID-19 Nasal Swab Test Market – Regional Analysis

On the basis of region, the global COVID-19 nasal swab test market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the global COVID-19 nasal swab test market over the forecast period, owing to rising number of product launches. For instance, in March 2021, Roche Diagnostics, a part of the Swiss pharmaceutical corporation Roche Holding AG, launched a new rapid antigen COVID-19 nasal swab test in partnership with SD Biosensor Inc., a Korean technology solutions provider. This COVID-19 diagnostic kit is a less invasive nasal test that provides results within 15 minutes.

Key players are focused on marketing strategies such as partnerships, collaborations, and others, which is expected to drive growth of the COVID-19 nasal swab test market. For instance, in April 2020, Accumen Inc., an American healthcare company, entered into a partnership with EnvisionTec, a German technology company, to produce 3D printed nasal swabs for diagnosis of COVID-19.

Figure 2: Global COVID-19 Nasal Swab Test Market Value (US$ 39.5 Mn), by Region, 2021

COVID-19 Nasal Swab Test  | Coherent Market Insights

Global COVID-19 Nasal Swab Test Market – Competitive Landscape

Major players operating in the global COVID-19 nasal swab test market include Abbott Laboratories, Roche Holding AG, Becton Dickinson & Company, 3M Corporation, BioMerieux SA, Lucira Health, Mesa Biotech, Inc.,Siemens Healthineers AG, QIAGEN N.V., Cepheid, LumiraDx Ltd., Fluidigm Corporation, Quidel Corporation, GenMark Diagnostics, Inc., Sherlock Biosciences, PrivaPath Diagnostics Limited, and OraSure Technologies, Inc.

COVID-19 infection is caused by SARS-CoV-2, which is a highly transmissible and life-threatening strain of coronavirus. Nasal swab is a method used for collecting clinical test samples of nasal secretions. Nasal swabs can be used for analysis of number of infectious diseases such as whooping cough, influenza, SARS, COVID-19, and others. Rising burden of COVID-19 cases across the world has created a huge opportunity for growth of COVID-19 nasal swab market. These nasal swabs can be used in laboratories as well as in the comfort of one’s home. The collection procedure must be carried out with extreme precautions as any contamination of the nasal swab may lead to wrong results. The collected nasal secretion sample is placed into a transporting medium that provides a stable environment to the sample. This transporting liquid medium is subjected to further diagnostic tests to detect the presence of SARS-CoV-2 in the nasal specimen.

Market Dynamics

Market players and private healthcare organizations are focused on conducting research activities for developing more efficient nasal swabs for detection of COVID-19 infection, which could contribute to the growth of the COVID-19 nasal swab test market over the forecast period. For instance, in March 2020, PATH, Mayo Clinic and Bill and Melinda Gates Foundation initiated an observational clinical study to compare the efficiency of foam nasal swabs and polyester nasal swabs in diagnosis of COVID-19 infection. This study was completed in October 2020, and it also focused on observing the trajectory of COVID-19 at different stages of infection.

Market players are focused on launch of products, which is expected to strengthen their position in the global COVID-19 nasal swab test market. For instance, in November 2020, Tata Medical and Diagnostics launched its product TataMD CHECK, a nasal swab test that is able to diagnose COVID-19 within 90 minutes.

Market players are involved in expanding their presence globally by entering into partnership with other companies in order to enhance distribution, this is expected to drive the growth of the COVID-19 nasal swab test market. For instance, in January 2021, iMFLUX, Inc., an American molding company entered into a partnership with Rhinostics, Inc., a Harvard University startup, to develop polypropylene COVID-19 nasal swab, which is cost effective and allows easy collection of nasal secretion.

Key features of the study:

  • This report provides an in-depth analysis of global COVID-19 nasal swab test market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global COVID-19 nasal swab test market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Roche Holding AG, Becton Dickinson & Company, 3M Corporation, BioMerieux SA, Lucira Health, Mesa Biotech, Inc.,Siemens Healthineers AG, QIAGEN N.V., Cepheid, LumiraDx Ltd., Fluidigm Corporation, Quidel Corporation, GenMark Diagnostics, Inc., Sherlock Biosciences, PrivaPath Diagnostics Limited, and OraSure Technologies, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global COVID-19 nasal swab test market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the COVID-19 nasal swab test market

Detailed Segmentation:

  • Global COVID-19 Nasal Swab Test Market, By Product Type:
    • Foam Tipped Swabs
    • Non-Woven
    • Others
  • Global COVID-19 Nasal Swab Test Market, By Diagnostics Type:
    • Molecular Diagnostics
    • CRISPR & Biosensors
    • Others
  • Global COVID-19 Nasal Swab Test Market, By Mode:
    • Point-of-Care
    • Non Point-of-Care
  • Global COVID-19 Nasal Swab Test Market, By End User:
    • Hospital & Clinic
    • Laboratories & Diagnostics Centers
    • Others
  • Global COVID-19 Nasal Swab Test Market, By Region:
    • North America
      • By Product Type:
        • Foam Tipped Swabs
        • Non-Woven
        • Others
      • By Diagnostics Type:
        • Molecular Diagnostics
        • CRISPR & Biosensors
        • Others
      • By Mode:
        • Point-of-Care
        • Non Point-of-Care
      • By End User:
        • Hospital & Clinic
        • Laboratories & Diagnostics Centers
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Foam Tipped Swabs
        • Non-Woven
        • Others
      • By Diagnostics Type:
        • Molecular Diagnostics
        • CRISPR & Biosensors
        • Others
      • By Mode:
        • Point-of-Care
        • Non Point-of-Care
      • By End User:
        • Hospital & Clinic
        • Laboratories & Diagnostics Centers
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Foam Tipped Swabs
        • Non-Woven
        • Others
      • By Diagnostics Type:
        • Molecular Diagnostics
        • CRISPR & Biosensors
        • Others
      • By Mode:
        • Point-of-Care
        • Non Point-of-Care
      • By End User:
        • Hospital & Clinic
        • Laboratories & Diagnostics Centers
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Foam Tipped Swabs
        • Non-Woven
        • Others
      • By Diagnostics Type:
        • Molecular Diagnostics
        • CRISPR & Biosensors
        • Others
      • By Mode:
        • Point-of-Care
        • Non Point-of-Care
      • By End User:
        • Hospital & Clinic
        • Laboratories & Diagnostics Centers
        • Others
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Foam Tipped Swabs
        • Non-Woven
        • Others
      • By Diagnostics Type:
        • Molecular Diagnostics
        • CRISPR & Biosensors
        • Others
      • By Mode:
        • Point-of-Care
        • Non Point-of-Care
      • By End User:
        • Hospital & Clinic
        • Laboratories & Diagnostics Centers
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Foam Tipped Swabs
        • Non-Woven
        • Others
      • By Diagnostics Type:
        • Molecular Diagnostics
        • CRISPR & Biosensors
        • Others
      • By Mode:
        • Point-of-Care
        • Non Point-of-Care
      • By End User:
        • Hospital & Clinic
        • Laboratories & Diagnostics Centers
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Roche Holding AG
    • Becton Dickinson & Company
    • 3M Corporation
    • BioMerieux SA
    • Lucira Health
    • Mesa Biotech, Inc.
    • Siemens Healthineers AG
    • QIAGEN N.V.
    • Cepheid
    • LumiraDx Ltd.
    • Fluidigm Corporation
    • Quidel Corporation
    • GenMark Diagnostics, Inc.
    • Sherlock Biosciences
    • PrivaPath Diagnostics Limited
    • OraSure Technologies, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Diagnostics Type
      • Market Snippet, By Mode
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • PEST Analysis
    • Industry Trends
    • Pipeline Analysis
    • Key Highlights
    • Epidemiology
    • Pricing Analysis
    • Reimbursement Scenario
    • Regulatory Scenario
    • Global Supply Chain Analysis
  4.  Global COVID-19 Nasal Swab Market - Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Epidemiology
    • Impact of COVID-19 on Demand and Supply of COVID-19 Nasal Swab Test
    • Impact of Covid-19 on the COVID-19 Nasal Swab Test Market
  5. Global COVID-19 Nasal Swab Test Market, By Product Type, 2017-2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Foam Tipped Swabs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Non-Woven
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  6. Global COVID-19 Nasal Swab Test Market, By Diagnostics Type, 2017-2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Molecular Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • CRISPR & Biosensors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  7. Global COVID-19 Nasal Swab Test Market, By Mode, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Point-of-Care
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Non Point-of-Care
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  8. Global COVID-19 Nasal Swab Test Market, By End User, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
      • Regional Trends
    • Hospital & Clinic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Laboratories & Diagnostics Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  9. Global COVID-19 Nasal Swab Test Market, By Region, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Diagnostics Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Mode, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Diagnostics Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Mode, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Diagnostics Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Mode, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Diagnostics Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Mode, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Diagnostics Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Mode, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Diagnostics Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Mode, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  10. Competitive Landscape
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Roche Holding AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Becton Dickinson & Company
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • 3M Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • BioMerieux SA
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Lucira Health
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Mesa Biotech, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Siemens Healthineers AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • QIAGEN N.V.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Cepheid
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • LumiraDx Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Fluidigm Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Quidel Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • GenMark Diagnostics, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Sherlock Biosciences
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • PrivaPath Diagnostics Limited
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • OraSure Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
    • Analyst Views
  11. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 52 market data tables and 38 figures on "COVID-19 Nasal Swab Test Market” - Global Forecast to 2028.

FAQgrowicon

Frequently Asked Questions

The global COVID-19 nasal swab test market is expected to exhibit a CAGR of 2.6% during the forecast period (2021-2028).
The market is estimated to be valued at US$ 111.3 Mn in 2021.
Abbott Laboratories, Roche Holding AG, Becton Dickinson & Company, 3M Corporation, BioMerieux SA, Lucira Health, Mesa Biotech, Inc.,Siemens Healthineers AG, QIAGEN N.V., Cepheid, LumiraDx Ltd., Fluidigm Corporation, Quidel Corporation, GenMark Diagnostics, Inc., Sherlock Biosciences, PrivaPath Diagnostics Limited, and OraSure Technologies, Inc. are some of the prominent players operating in the market.
The market is expected to be valued at US$ 133.2 Mn in 2028.
North America is the prominent region in the market.
Increasing number product launches, rising cases of COVID-19, increasing research and development activities by the market players, and increasing strategic collaborations among the market players are some of the driving factors, which are expected to drive growth of the market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.